Location History:
- Middlesex, GB (2022 - 2024)
- Brentford, GB (2022 - 2024)
Company Filing History:
16 out of 68 
3 out of 282 
Years Active: 2022-2025
Title: Matteo Donega: Innovator in Neurostimulation Technology
Introduction
Matteo Donega is a prominent inventor based in Middlesex, GB, known for his significant contributions to the field of neurostimulation technology. With a total of 16 patents to his name, Donega has been at the forefront of developing innovative solutions aimed at improving health outcomes.
Latest Patents
One of Donega's latest patents is a neurostimulation device designed for blocking blood flow between electrodes. This device allows for non-destructive stimulation of neural activity in proximity to a blood vessel. It comprises a catheter for insertion into the blood vessel, featuring a proximal electrode offset from a distal electrode along the catheter's length. An insulator positioned between these electrodes can change configurations to either allow the catheter to travel within the blood vessel or block blood flow between the electrodes. This innovative design enables the application of electrical signals to stimulate neural activity effectively. Another notable invention involves the stimulation of a nerve supplying the spleen, which can modulate levels of pro- and anti-inflammatory molecules, thereby offering new methods for treating inflammatory disorders with minimized off-target effects.
Career Highlights
Throughout his career, Matteo Donega has worked with notable companies such as Galvani Bioelectronics Limited and UCL Business Plc. His work has significantly impacted the development of neurostimulation technologies, showcasing his expertise and commitment to advancing medical science.
Collaborations
Donega has collaborated with talented individuals in his field, including Daniel John Chew and Isha Gupta. These partnerships have contributed to the innovative projects he has undertaken.
Conclusion
Matteo Donega's work in neurostimulation technology exemplifies the potential of innovation in addressing complex medical challenges. His patents and collaborations reflect a dedication to improving health outcomes through advanced technology.